PROVENTION BIO, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 9th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 9th, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 25, 2017, is made and entered into by and between PROVENTION BIO, INC., a Delaware corporation with its principal executive offices located at 110 Old Driftway Lane, Lebanon, NJ 08833 (the “Company”), and each of the purchasers listed on Schedule A hereto (the “Purchasers”).
Cue Biopharma, Inc. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 21st, 2017 • Cue Biopharma, Inc. • Delaware
Contract Type FiledSeptember 21st, 2017 Company JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December ___, 2016, is made and entered into by and between Cue Biopharma, Inc., a Delaware corporation (formerly Imagen Biopharma, Inc.) with its principal executive offices located at 675 W. Kendall St., Cambridge, MA 02142 (the “Company”), and each of the purchasers listed on Schedule A hereto (the “Purchasers”).
Imagen Biopharma, Inc. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 21st, 2017 • Cue Biopharma, Inc. • California
Contract Type FiledSeptember 21st, 2017 Company JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 15, 2015, is made and entered into by and between Imagen Biopharma, Inc., a Delaware corporation with its principal executive offices located at 401 Wilshire Boulevard, Suite 1020 Santa Monica, CA 90401 (the “Company”), and each of the purchasers listed on Schedule A hereto (the “Purchasers”).